Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
500
NCT04671693
A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.
Phase: N/A
Role: Collaborator
Start: Dec 24, 2020
Completion: Apr 24, 2029